Korro Bio, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $198.6M
- Price
- $13.18
- % Change (Daily % change from the live per-ticker quote feed.)
- +1.70%
- Volume
- 45.7K
About
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Quick stats
Shares outstanding14.7M
Computed float11.3M
Float / shares76.5%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001703647
Websitehttps://www.korrobio.com
AI Summary
AI-generated1/21
minorneutraloperations update
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Korro Bio granted a non-statutory stock option to a newly hired employee as an employment inducement under Nasdaq Listing Rule 5635(c)(4).
The option covers 600 shares at an exercise price of $13.35 per share, which was the closing price on the grant date of August 12, 2026.
The award has a ten-year term and vests over four years, with 25% vesting on the first anniversary and the remainder in monthly installments.